Dual myeloperoxidase-antineutrophil cytoplasmic antibody- and antiglomerular basement membrane antibody-positive cases associated with prior pulmonary fibrosis: a report of four cases.
BACKGROUND
Both myeloperoxidase-associated antineutrophil cytoplasmic antibody (MPO-ANCA) and antiglomerular basement membrane antibody (anti-GBM Ab) positivity have been demonstrated in patients with rapidly progressive glomerulonephritis (RPGN), either with or without pulmonary hemorrhage; however, the implications of these antibodies in such patients have not yet been elucidated. The cases with dual positive antibodies were studied clinically, serologically, and pathologically, and the implications of antibodies are discussed here.


METHODS
Four patients with prior pulmonary fibrosis, who subsequently developed RPGN and pulmonary hemorrhage, were studied clinically, serologically, and pathologically. The clinical data were reviewed extensively and the dual positive antibodies were detected by enzyme-linked immunosorbent assays. Pathological studies were performed with a renal biopsy in one patient, a gastric biopsy in another patient, and autopsy materials in the remaining 2 patients.


RESULTS
All 4 patients had prior pulmonary fibrosis before the symptoms of RPGN when the dual positivity of MPO-ANCA and anti-GBM Ab was detected. Three cases were accompanied by pulmonary hemorrhage around the time of RPGN whereas the remaining case demonstrated pulmonary hemorrhage a few years later. Renal tissue specimens in 3 cases showed circumferential crescents and linear immunoglobulin G deposits along the glomerular capillary loops in glomeruli. Two autopsy specimens revealed vasculitis of the small arteries and arterioles of the kidney, and one of them showed similar vasculitic findings in both the gastrointestinal tract walls and the adipose tissues of the adrenal glands. Additionally, a case with pulmonary hemorrhage occurring after remission was associated with re-elevated MPO-ANCA levels but without anti-GBM Ab positivity. A gastric biopsy was unremarkable and non-contributory for the diagnosis, but this case showed vasculitic symptoms of peripheral neuritis and retinal hemorrhage. Taken together, all 4 cases demonstrated prior pulmonary fibrosis and dual positivity of MPO-ANCA as well as anti-GBM Abs at the time of RPGN, and were associated with either pulmonary hemorrhage or its occurrence thereafter.


CONCLUSIONS
Four cases that showed prior pulmonary fibrosis as well as subsequent RPGN and pulmonary hemorrhage were both MPO-ANCA- and anti-GBM Ab-positive at the time of RPGN. The glomeruli disclosed features compatible with anti-GBM Ab disease, but the clinical and pathological vasculitic manifestations, including prior pulmonary fibrosis that might be an early manifestation of ANCA disease, suggested the occurrence of MPO-ANCA-associated vasculitis. Furthermore, 1 case subsequently showed repetitive pulmonary hemorrhage with re-elevated MPO-ANCA positivity but without anti-GBM Ab positivity, and this event was possibly due to MPO-ANCA-associated alveolar capillaritis. As anti-GBM Ab disease is generally thought not to manifest the clinical and pathological features of vasculitis excluding the kidney, MPO-ANCA might be a key factor regarding the occurrence of this dual positive disease.
First Department of Internal Medicine, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan. kiminaka@krd.biglobe.ne.jp
Kimimasa
K
Nakabayashi
Yasunori
Y
Fujioka
Toshihiko
T
Nagasawa
Tsuneo
T
Kimura
Kaoruko
K
Kojima
Yoshihiro
Y
Arimura
Yasuhiro
Y
Arimura
Akira
A
Yamada
D000328:Adult; D000368:Aged; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000276:immunology*; D001323:Autoantibodies / Q000276:immunology*; D017809:Fatal Outcome; D005260:Female; D005921:Glomerulonephritis / Q000150:complications / Q000276:immunology*; D006470:Hemorrhage / Q000209:etiology / Q000276:immunology; D006801:Humans; D008171:Lung Diseases / Q000209:etiology / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009195:Peroxidase / Q000276:immunology*; D011658:Pulmonary Fibrosis / Q000150:complications* / Q000276:immunology
D019268:Antibodies, Antineutrophil Cytoplasmic; D001323:Autoantibodies; C051951:antiglomerular basement membrane antibody; D009195:Peroxidase
Kidney Int. 2004 Oct;66(4):1535-40
15458448
Respirology. 2004 Jun;9(2):190-6
15182268
Mod Rheumatol. 2009;19(4):420-6
19521745
Am J Med. 1991 Jul;91(1):59-66
1677531
Nihon Jinzo Gakkai Shi. 2008;50(1):64-8
18318246
J Am Soc Nephrol. 1997 Mar;8(3):376-85
9071706
Clin Exp Nephrol. 2009 Dec;13(6):605-13
19506990
Clin Nephrol. 1993 Mar;39(3):125-36
7681736
Ann Intern Med. 1990 Nov 1;113(9):656-63
2221646
Lancet. 1983 Dec 17;2(8364):1390-3
6140495
Am J Med Sci. 2009 Aug;338(2):148-51
19680020
Clin Nephrol. 1989 Dec;32(6):251-5
2612068
Nihon Jinzo Gakkai Shi. 2009;51(4):490-5
19601559
Nihon Rinsho Meneki Gakkai Kaishi. 1999 Oct;22(5):342-7
10616288
Am J Kidney Dis. 2004 Mar;43(3):e26-30
14981638
Kidney Int. 2001 Nov;60(5):2025-30
11703623
Nihon Jinzo Gakkai Shi. 1995 Mar;37(3):207-11
7731110
Nephrol Dial Transplant. 1998;13 Suppl 1:16-20
9507492
Intern Med. 1992 Feb;31(2):239-43
1318119
Am J Kidney Dis. 2005 Aug;46(2):253-62
16112043
Kidney Int. 2003 Mar;63(3):1164-77
12631105
J Am Soc Nephrol. 1997 Nov;8(11):1795-800
9355084
Nihon Jinzo Gakkai Shi. 1994 Jun;36(6):769-73
8084079
Acta Pathol Jpn. 1986 Apr;36(4):595-604
2873708
Arch Pathol Lab Med. 1980 Jun;104(6):300-2
6892868
Nihon Kokyuki Gakkai Zasshi. 2007 Dec;45(12):921-6
18186236
Kidney Int. 1990 Mar;37(3):965-70
2179617
Mod Pathol. 1993 Sep;6(5):526-30
8248108
Nihon Jinzo Gakkai Shi. 1998 Nov;40(8):591-6
9893458
Ryumachi. 1995 Feb;35(1):46-55
7732490
Am J Kidney Dis. 2000 May;35(5):954-7
10793033
Nihon Kyobu Shikkan Gakkai Zasshi. 1997 Dec;35(12):1356-62
9567081
Clin Nephrol. 1991 Sep;36(3):107-13
1657470
Clin Nephrol. 1990 May;33(5):257-8
2354567